title: Anatomical Location of Pathology Is Predictive of Prolonged Fluoroscopy Time During ERCP: A Multicenter American Study.
abstract: BACKGROUND
  Different factors have been associated with prolonged fluoroscopy time (FT) during endoscopic retrograde cholangiopancreatography (ERCP).
  
  
  OBJECTIVE
  We hypothesize that FT depends on both the anatomical location of the pathology managed during ERCP and the complexity of the ERCP.
  
  
  METHODS
  Three centers participated in a retrospective multi-center cohort study. Data on patient demographics, ERCP complexity, and the location of pathology were collected. The relationships between FT and the location of pathology, ERCP complexity, patient demographics, and ERCP maneuvers, respectively, were analyzed. Prolonged FT was defined as a FT > 10 min.
  
  
  RESULTS
  A total of 442 cases underwent ERCP in three different centers (301 cases, 76 cases, and 65 cases in centers A, B, and C, respectively) by six endoscopists. The median FT for all cases was 282 (range 8-3,516) s. Mean FT increased progressively according to anatomical location in the order extrahepatic cases {n = 298; mean FT 292 [95 % confidence interval (CI) 263-322] s}, pancreatic cases [n = 27; mean FT 359 (95 % CI 200-517) s], and intrahepatic cases [n = 117; mean FT 736 s (95 % CI 635-836) s]. Mean FT increased progressively with the complexity scale, with mean FT for Grade I, 218 (95 % CI 138-299) s; Grade II, 295 (95 % 261-329) s; Grade III, 586 (95 % CI 508-663) s; Grade IV, 636 (95 % CI 437-834) s. Multivariable analysis confirmed that prolonged FT was independently associated with anatomical location of the targeted pathology during ERCP-but not with ERCP complexity and endoscopy center.
  
  
  CONCLUSIONS
  Prolonged FT during ERCP is associated most strongly with intrahepatic cases. FT can be used most effectively as a quality measure if it is stratified according to presence or absence of intrahepatic cases.
authors: Division of Gastroenterology, Cancer Treatment Centers of America, 10109 E 79th St, Tulsa, OK, 74133, USA, amerkt2000@yahoo.com.
authors: Amer A
authors: AA
authors: Alkhatib
authors: Ala A
authors: AA
authors: Abdel Jalil
authors: Douglas O
authors: DO
authors: Faigel
authors: Rahul
authors: R
authors: Pannala
authors: Michael
authors: M
authors: Crowell
authors: M E
authors: ME
authors: Harrison
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001660:Biliary Tract Diseases / Q000000981:diagnostic imaging* / Q000601:surgery*; D002760:Cholangiopancreatography, Endoscopic Retrograde; D005260:Female; D005471:Fluoroscopy / Q000706:statistics & numerical data*; D006801:Humans; D008297:Male; D008875:Middle Aged; D061646:Operative Time; D010182:Pancreatic Diseases / Q000000981:diagnostic imaging* / Q000601:surgery*; D011829:Radiation Dosage; D012189:Retrospective Studies; D015607:Stents; D016896:Treatment Outcome
references: Int J Qual Health Care. 1999 Jun;11(3):187-92
references: 10435838
references: World J Gastrointest Endosc. 2011 Jul 16;3(7):140-4
references: 21860683
references: Gastrointest Endosc. 2007 Jul;66(1):84-9
references: 17591479
references: Postgrad Med J. 2005 Oct;81(960):660-2
references: 16210465
references: Gastrointest Endosc. 2010 Jul;72(1):58-65
references: 20421102
references: Gastrointest Endosc. 2011 May;73(5):868-74
references: 21377673
references: Gastrointest Endosc. 2002 Apr;55(4):552-7
references: 11923771
references: Gastrointest Endosc. 2010 Jul;72(1):50-7
references: 20620272
references: Radiat Prot Dosimetry. 2003;106(3):241-6
references: 14690325
references: Gastrointest Endosc. 1996 Sep;44(3):287-92
references: 8885348
references: Am J Gastroenterol. 2013 Aug;108(8):1224-30
references: 23912400
references: Dig Dis Sci. 2006 May;51(5):909-14
references: 16718536
references: Can J Gastroenterol. 2011 Oct;25(10):555-9
references: 22059160
references: Dig Dis Sci. 2012 May;57(5):1134-43
references: 22297651